Evidence map›Paper›PMID 27152845›Full record

ArticleBlood cancer journal2016

Differential clinical and prognostic impact of myeloid sarcoma vs medullary myeloid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy.

Z Chen, W Wang, J E Cortes, E Liu, R N Miranda, C Zhao, J Yuan, X Lu, W Yang, M D Ameri and 3 more

Open access · goldAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood cancer journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 2 countries.

Z ChenDepartment of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
W WangDepartment of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
J E CortesDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
E LiuDepartment of Pathology, Institute of Hematology & Blood Diseases Hospital, Tianjin, China.
R N MirandaDepartment of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
C ZhaoDepartment of Pathology, University of Iowa, Iowa City, IA, USA.
J YuanDepartment of Pathology, University of Nebraska, Omaha, NE, USA.
X LuDepartment of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
W YangDepartment of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
M D AmeriDepartment of Pathology, City of Hope National Medical Center, Duarte, CA, USA.
H M KantarjianDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
L J MedeirosDepartment of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
S HuDepartment of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
The University of Texas MD Anderson Cancer Center · USCity Of Hope National Medical Center · USFudan University · CNInstitute of Hematology & Blood Diseases Hospital · CNUniversity of Iowa · USUniversity of Nebraska at Omaha · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAgedAged, 80 and overBlast CrisisBone MarrowDiagnosis, DifferentialFemaleHumansLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMaleMiddle AgedPrognosisProtein Kinase InhibitorsProtein-Tyrosine KinasesSarcoma, MyeloidSurvival AnalysisProtein Kinase InhibitorsProtein-Tyrosine Kinases

Identifiers

PMID27152845
PMCPMC4916296
OpenAlexW2347130568

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.